WASHINGTON (CN) - The Food and Drug Administration has issued a regulation requiring hospitals and blood banks to establish a system to identify blood and components previously donated by a person whose later blood donation tests positive for hepatitis C. The hepatitis C may be found by testing, reviewing records, or other reliable means. Since the donor's blood may transmit hepatitis C, the FDA requires collectors to quarantine any of the donor's unexpired blood, and notify centers that received the blood to quarantine it and test the donor. Centers that have used the blood in transfusions must notify recipients. The regulation also changes the human immunodeficiency virus rules to be consistent with the new hepatitis C rules. for details and other new regulations.
Read the Top 8
Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.
Additional Reads
-
-
FDA moves to ease rules for blood donations from gay men January 27, 2023
-
US study: Over half of car crash victims had drugs in system December 13, 2022 -
FDA clears 1st fecal transplant treatment for gut infection November 30, 2022